{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:12:23Z","timestamp":1791000743564,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbrc.2019.09.084","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T17:53:40Z","timestamp":1569347620000},"page":"854-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-\u03baB-TNF-\u03b1 signaling pathway in a PPAR\u03b3-dependent manner"],"prefix":"10.1016","volume":"519","author":[{"given":"Zhuo","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2019.09.084_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2019.09.084_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.bbrc.2019.09.084_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability","volume":"19","author":"McGlynn","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbrc.2019.09.084_bib4","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2019.09.084_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00018-012-1046-x","article-title":"Peroxisome proliferator-activated receptor-gamma as a therapeutic target for hepatic fibrosis: from bench to bedside","volume":"70","author":"Zhang","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2019.09.084_bib6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gut.2005.079194","article-title":"Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats","volume":"55","author":"Leclercq","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2019.09.084_bib7","article-title":"Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis","volume":"96","author":"Tag","year":"2015","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.bbrc.2019.09.084_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.28932","article-title":"Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis","volume":"65","author":"Samur","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.09.084_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818787400","article-title":"Cholestatic liver diseases: new targets, new therapies","volume":"11","author":"Santiago","year":"2018","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.bbrc.2019.09.084_bib10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/ATVBAHA.117.309630","article-title":"Activation of adiponectin receptor regulates proprotein convertase subtilisin\/kexin type 9 expression and inhibits lesions in apoE-deficient mice","volume":"37","author":"Sun","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2019.09.084_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biomaterials.2018.08.063","article-title":"Biodegradable and elastomeric vascular grafts enable vascular remodeling","volume":"183","author":"Zhu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2019.09.084_bib12","doi-asserted-by":"crossref","first-page":"794862","DOI":"10.1155\/2015\/794862","article-title":"Hepatocyte-specific ablation of PP2A catalytic subunit alpha attenuates liver fibrosis progression via TGF-beta1\/Smad signaling","volume":"2015","author":"Lu","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2019.09.084_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-3155-9-15","article-title":"Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice","volume":"9","author":"Pulavendran","year":"2011","journal-title":"J.\u00a0Nanobiotechnol."},{"key":"10.1016\/j.bbrc.2019.09.084_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1194\/jlr.M080440","article-title":"25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism","volume":"59","author":"Liu","year":"2018","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2019.09.084_bib15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.29540","article-title":"C\/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice","volume":"67","author":"Liu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.09.084_bib16","doi-asserted-by":"crossref","first-page":"41888","DOI":"10.1038\/srep41888","article-title":"Possible involvement of nitric oxide in enhanced liver injury and fibrogenesis during cholestasis in cytoglobin-deficient mice","volume":"7","author":"Van Thuy","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2019.09.084_bib17","first-page":"1545","article-title":"Reduced triglyceride accumulation due to overactivation of farnesoid X receptor signaling contributes to impaired liver regeneration following 50% hepatectomy in extracholestatic liver tissue","volume":"17","author":"Jia","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2019.09.084_bib18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0024-3205(03)00423-5","article-title":"Change in lipid profile and impairment of endothelium-dependent relaxation of blood vessels in rats after bile duct ligation","volume":"73","author":"Ji","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2019.09.084_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.09.084_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","article-title":"MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-kappaB-TNFalpha pathway","volume":"70","author":"Zhang","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2019.09.084_bib21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.28000","article-title":"Stimulation of nuclear receptor peroxisome proliferator-activated receptor-gamma limits NF-kappaB-dependent inflammation in mouse cystic fibrosis biliary epithelium","volume":"62","author":"Scirpo","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.09.084_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.20452\/pamw.1023","article-title":"Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease","volume":"121","author":"Saryusz-Wolska","year":"2011","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.bbrc.2019.09.084_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2036.2008.03723.x","article-title":"Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis","volume":"28","author":"Idilman","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2019.09.084_bib24","first-page":"1008","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.09.084_bib25","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23941","article-title":"Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice","volume":"52","author":"Gupte","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.09.084_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.21687","article-title":"Effects of rosiglitazone on the liver histology and mitochondrial function in ob\/ob mice","volume":"46","author":"Garcia-Ruiz","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.09.084_bib27","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1007\/s10620-007-9756-x","article-title":"Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis","volume":"52","author":"Tahan","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbrc.2019.09.084_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3746\/pnf.2019.24.2.103","article-title":"Health benefits of carotenoids: a role of carotenoids in the prevention of non-alcoholic fatty liver disease","volume":"24","author":"Lee","year":"2019","journal-title":"Prev. Nutr. Food Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19318121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19318121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:40:45Z","timestamp":1757763645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19318121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0006291X19318121"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.084","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-\u03baB-TNF-\u03b1 signaling pathway in a PPAR\u03b3-dependent manner","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}